Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 55 holding rows worth $841,887,000.

Accession
0001425738-14-000002
Filed
2014-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2014

A holdings report, 55 entries on the cover page, a total value of $841,887,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $841,887,000 with VALUE read as thousands by filing date, 13F file number 028-12776. A later restatement replaced it, so the quarter does not use it. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ACTAVIS PLCG0083B108SHS246,398$50,721,000thousands by filing date
HCA Healthcare Inc40412C101COM872,589$45,811,000thousands by filing date
AGILENT TECHNOLOGIES INC COM00846U101Stock772,994$43,226,000thousands by filing date
VALEANT PHARMACEUTICALS INTL91911K102COM297,136$39,171,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM513,198$35,549,000thousands by filing date
TENET HEALTHCARE CORP COM NEW88033G407Stock789,562$33,801,000thousands by filing date
GLOBUS MED INC CL A379577208Stock1,062,952$28,264,000thousands by filing date
HEARTWARE INTL INC422368100COM291,974$27,381,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock1,184,347$25,132,000thousands by filing date
RITEAID CORP767754104COM3,801,800$23,837,000thousands by filing date
HEALTHWAYS INC422245100COM1,354,832$23,222,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock4,882,930$22,950,000thousands by filing date
Bristol-Myers Squibb Company110122108COM418,500$21,741,000thousands by filing date
INSULET CORP COM45784P101Stock457,048$21,673,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock559,611$21,439,000thousands by filing date
CHIMERIX INC COM16934W106Stock895,006$20,442,000thousands by filing date
NUVASIVE INC670704105COM521,301$20,023,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock142,886$19,815,000thousands by filing date
GW PHARMACEUTICALS PLC36197T103ADS323,583$19,211,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK1,001,060$18,199,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK172,092$17,922,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM443,326$17,627,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM8,496,538$17,588,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM51,113$16,857,000thousands by filing date
CELLDEX THERAPEUTICS INC NEW15117B103COM863,947$15,266,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock294,612$15,258,000thousands by filing date
ACCURAY INC DEL004397105COM1,475,360$14,163,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK1,090,428$13,892,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK310,727$13,032,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS624,869$12,541,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK391,627$12,450,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock452,194$11,712,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM528,070$10,905,000thousands by filing date
ENDOLOGIX INC29266S106COM795,095$10,233,000thousands by filing date
ACHAOGEN INC004449104COM653,700$10,106,000thousands by filing date
MODEL N INC607525102COM854,378$8,638,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM493,183$8,113,000thousands by filing date
XOMA CORP DEL98419J107COM1,522,543$7,932,000thousands by filing date
INOGEN INC45780L104COM460,923$7,610,000thousands by filing date
DERMA SCIENCES INC249827502COM PAR $.01598,077$7,584,000thousands by filing date
BIOSPECIFICS TECHNOLOGIES090931106COM271,620$7,040,000thousands by filing date
IGNYTA INC451731103COM600,000$4,980,000thousands by filing date
GERON CORP374163103COM2,117,555$4,405,000thousands by filing date
AMBIT BIOSCIENCES CORP02318X100COM367,602$3,353,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK173,408$2,832,000thousands by filing date
CERUS CORP157085101COM586,205$2,814,000thousands by filing date
GENOCEA BIOSCIENCES INC372427104COM125,244$2,278,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock64,167$815,000thousands by filing date
OPHTHOTECH CORP683745103COM19,374$692,000thousands by filing date
Cynosure, Inc.232577205COM20,000$586,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$379,000thousands by filing date
MARKET VECTORS BIOTECH ETF57060U183BIOT3,208$292,000thousands by filing date
ALLERGAN INC018490102COM1,786$222,000thousands by filing date
AFFYMETRIX INC00826T108COM13,500$96,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328601COM NEW10,000$66,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001425738-14-000002this filing2014-05-15acceptance time not in the bulk data set
13F-HR/A 0001425738-14-000004 base2014-08-19acceptance time not in the bulk data set